JESSICA BARTHELEMY: Open Payments
NPI 1588112825 · VESTAVIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 40 payments from 12 companies in 2025. Trend: 2023 $617 · 2024 $663 · 2025 $805
Food & beverage: $805
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $194 |
| SCILEX PHARMACEUTICALS INC. | 11 | $137 |
| Abbott Laboratories | 1 | $106 |
| Indivior Inc. | 3 | $99 |
| Boston Scientific Corporation | 3 | $53 |
| SPR Therapeutics, Inc | 5 | $48 |
| PFIZER INC. | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Braeburn Inc. | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: PROCLAIM, SUBLOCADE, BOTOX, ZTLido, UBRELVY, ELYXYB - CELECOXIB, SPRINT PNS System, NURTEC ODT.
Industry payments across AL — which companies pay providers there.
